Home Studieprotocollen MM CARTITUDE-6

Deelnemende ziekenhuizen

In voorbereiding

  • Radboudumc (E. de Kort)

Officiƫle titel

A phase 3 randomized study comparing daratumumab, bortezomib, lenalidomide and dexamethasone (DVRd) followed by ciltacabtagene autoleucel versus daratumumab, bortezomib, lenalidomide and dexamethasone (DVRd) followed by autologous stem cell transplant (ASCT) in participants with newly diagnosed multiple myeloma who are transplant eligible

Studiedocumenten

Volgt